Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy and Safety of ETX 018810 in Subjects With Diabetic Peripheral Neuropathic Pain

NCT04688671 is registered in ClinicalTrials.gov with Eliem Therapeutics (UK) Ltd. as lead sponsor.

NCT NCT04688671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04688671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy and Safety of ETX 018810 in Subjects With Diabetic Peripheral Neuropathic Pain
Lead sponsor
Eliem Therapeutics (UK) Ltd.
Phase
Phase 2
Overall status
Completed
Start date
November 9, 2020
Completion date
February 18, 2022
Enrollment
167 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic peripheral neuropathic pain, diabetic peripheral neuropathy